Debra Dorotea

Publications
CV
Public outreach and news

Articles

Article: HEPATOLOGY. 2024;79(6):1337-1351
Wnt/β-catenin and NFκB signaling synergize to trigger growth-factor-free regeneration of adult primary human hepatocytes
Oliva-Vilarnau N; Beusch CM; Sabatier P; Sakaraki E; Tjaden A; Graetz L; Buettner FA; Dorotea D; Nguyen M; Bergqvist F; Sundstrom Y; Mueller S; Zubarev RA; Schulte G; Tredup C; Gramignoli R; Tietge UJF; Lauschke VM
Journal article: EXPERIMENTAL AND MOLECULAR MEDICINE. 2022;54(8):1086-1097
Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress
Dorotea D; Jiang S; Pak ES; Son JB; Choi HG; Ahn S-M; Ha H
Journal article: FRONTIERS IN PHARMACOLOGY. 2022;13:925993
Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction
Rahman MA; Akter S; Dorotea D; Mazumder A; Uddin MN; Hannan MA; Hossen MJ; Ahmed MS; Kim W; Kim B; Uddin MJ
Journal article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(15):7989
Knockdown of PEX16 Induces Autophagic Degradation of Peroxisomes
Wei X; Maharjan Y; Dorotea D; Dutta R-K; Kim D; Kim H; Mu Y; Park C; Park R
Journal article: BIOMOLECULES & THERAPEUTICS. 2021;29(1):41-51
KF-1607, a Novel Pan Src Kinase Inhibitor, Attenuates Obstruction-Induced Tubulointerstitial Fibrosis in Mice
Dorotea D; Lee S; Lee SJ; Lee G; Son JB; Choi HG; Ahn S-M; Ha H
Journal article: ARCHIVES OF PHARMACAL RESEARCH. 2021;44(1):49-62
Activation of β₂ adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases
Dorotea D; Ha H
Journal article: PHYTOMEDICINE. 2021;80:153393
Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk
Jiang S; Oh D-S; Dorotea D; Son E; Kim D-S; Ha H
Journal article: BIOMOLECULES & THERAPEUTICS. 2020;28(3):213-221
Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury
Uddin MJ; Dorotea D; Pak ES; Ha H
Journal article: FRONTIERS IN PHARMACOLOGY. 2020;11:265
Recent Insights Into SREBP as a Direct Mediator of Kidney Fibrosis via Lipid-Independent Pathways
Dorotea D; Koya D; Ha H
Journal article: ANTIOXIDANTS & REDOX SIGNALING. 2019;31(18):1339-1351
Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress
Piao L; Dorotea D; Jiang S; Koh EH; Oh GT; Ha H
Journal article: EXPERIMENTAL AND MOLECULAR MEDICINE. 2018;50(4):1-14
Orally active, species-independent novel A₃ adenosine receptor antagonist protects against kidney injury in db/db mice
Dorotea D; Cho A; Lee G; Kwon G; Lee J; Sahu PK; Jeong LS; Cha DR; Ha H
Journal article: PHARMACOLOGY. 2018;102(3-4):180-189
A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats
Dorotea D; Kwon G; Lee JH; Saunders E; Bae YS; Moon SH; Lee SJ; Cha DR; Ha H
Journal article: ONCOTARGET. 2017;8(52):89746-89760
TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease
Lee SM; Dorotea D; Jung I; Nakabayashi T; Miyata T; Ha H

Employments

Postdoctoral Researcher, Department of Laboratory Medicine, Karolinska Institutet, 2024-2026

Articles

Employments

Degrees and Education

Visiting research fellowships

News from KI

Events from KI